Two BC researchers have combined forces to develop a blood test that will identify patients at high risk for Chronic Obstructive Pulmonary Disease (COPD) lung attacks. This much needed test will help medical professionals provide better treatment and ultimately lead to patients with fewer attacks, and reduced hospitalization and emergency visits.
One year ago today marked the beginning of “Genome: The Power and the Promise” — a landmark event, presented by the Gairdner Foundation and Genome Canada, to celebrate a decade of progress and discovery in genomics research.
ANNOUNCEMENT – The Office of the Privacy Commissioner of Canada (OPC) has issued a call for proposals under its 2014-15 Contributions Program for project proposals aimed at promoting privacy and the protection of personal information in the private sector.
A team of clinical researchers led by CHU de Québec has received CAN$10.5 million from Génome Québec, Genome Canada, CIHR, Genome Alberta and other partners to recruit 5,600 pregnant women in Canada to study the potential of using DNA sequencing alone or in a contingent model with first trimester serum markers as a non-invasive method for detecting birth defects.
From November 1 to December 31, 2013, Statistics Canada is inviting researchers to apply for access to blood, urine and DNA samples from the Canadian Health Measures Survey (CHMS) for use in health studies. The biospecimens are available to any Canadian researcher that completes a review process and would benefit from a national population survey of about 5,600 participants per collection cycle.
Genome Canada is delighted to highlight the recent appointment of five new members to its Board of Directors. They include:
Fiona Brinkman, Professor, Molecular Biology and Biochemistry at Simon Fraser University
Jay Ingram, Broadcaster and Science Writer
Kim McConnell, Founder and former CEO, AdFarm
Moura Quayle, Professor, Strategic Design, Sauder School of Business, University of British Columbia
Donald Ziraldo, Co-founder, Inniskillin Wines